Kevin Schug delves into modern microscale liquid chromatography (LC) stationary phases.
turbomotion046/stock.adobe.com
Kevin Schug delves into modern microscale liquid chromatography (LC) stationary phases.
In an effort to better understand the current application potential of microscale liquid chromatography (micro-LC), I picked up a few recent review articles from the literature. What one immediately appreciates from glancing through the literature for such information is that there are a lot of different configurations and alternative formats, which can be placed under the micro-LC umbrella. I enjoyed reading reviews on openâtubular LC (1), LCâon-a-chip (2), the use of nanomaterials in LC (3), and LC separations on microfluidic devices (4), to name a few.
In general, there is an interest in moving to smaller scales because better kinetic and chromatographic performance is achievable. In recent years, significant commercial success has been realized by different commercial manufacturers, from both established and start-up companies, moving to smaller scales. Still, there is much that can be done to advance these smaller formats.
Taking LC from traditional analytical scale down to microscale brings with it several challenges. There are many different aspects to creating appropriate pumping, injection, separation, and detection systems at the microscale, including the fluidic connections between the components. If you are like me, and your primary experience with LC columns is stainless steel tubes packed with functionalized silica, then perhaps the most striking thing about the state-of-the-art in micro-LC is all of the different stationary phase types, which have been investigated.
Some advancements in stationary phases in micro-LC were born out of necessity. For example, packed beds require the use of frits to hold the packing in place. For capillaries and microfluidic devices, some special techniques are needed to create appropriate structures to accomplish this task. Thus, alternative approaches, such as porous-layer or wall-coated open-tubular, monolithic, or hybrid stationary phase architectures become attractive. Creating separation devices at a smaller scale also requires much less in terms of potentially costly materials, which could be used to create innovative stationary phases. As a result, a great deal of innovation has occurred, the vast majority of which is yet to be commercialized.
Open-tubular columns can achieve more favourable separation kinetics compared to packed beds, but the columns need to be less than 10–30 µm internal diameter in order for deleterious mass transfer effects not to dominate. Probably the greatest advancements in open-tubular LC have been in ion exchange separations. The multi-point adsorption of charged polymeric particles on the walls of small internal diameters capillaries or microfluidic channels is fairly straightforward and creates stationary phases that are very robust.
Open-tubular stationary phase development is a fertile ground for research; from metal-organic frameworks (MOF) to polymeric particles to various nanomaterial configurations, and combinations thereof, much has been investigated. The exceedingly high porosity and surface-to-volume ratio of MOFs have been reported to provide very high efficiency separations, up to 150,000 plates per metre. While ion exchange formats are perhaps more developed, a great deal of application base has to do with the type of detection available. Likely to drive further development of open-tubular separation formats will be more reliable interfacing to mass spectrometric detection, so that biological molecules from small sample aliquots can be reliably analyzed. Other detection systems are not specific enough for use in, for example, real-world proteomics applications.
A surprising amount of work has been performed in the development of nanomaterials as stationary phases. Nanomaterials have a wide range of favourable properties, including high surface-to-volume ratios, ease of functionalization, and wide pH stability. Their biggest drawback for their direct use is the high back pressure that can be expected to accompany pumped flows through packed beds of nanoparticles. Pumping through a packed bed of 50 nm particles requires a 10,000 times higher pressure than pumping through a bed of 5 µm particles. As a result, it is perhaps more reasonable to consider entraining nanoparticles in a hybrid framework; researchers have incorporated nanoparticles into monolithic phases and shown significant improvements in separations as a result.
Lab-on-a-chip or micro-total analysis systems have been attractive concepts for many decades. Beyond straightforward separations of molecules by LC, other onâchip components could include mixers, extraction phases, or reactor units. Still, many of the same considerations exist in terms of having the appropriate supporting peripherals (pumps, detectors, connections) available to make them function properly. The general consensus seems to be that incorporating these peripherals directly onto a lab-on-a-chip or micro-total analysis system is a big challenge. Extractions and separations are now quite straightforward with the plethora of strategies available; this is likely why you see more commercial manufacturers offering microscale separations as a component of a larger system, rather than seeking to create the instrument that will fit in the palm of your hand. That said, there have also been major recent advances in commercial portable LC systems in the recent past.
There has been an increasing interest in capillary-scale LC in the past five years. For many years, researchers have packed their own capillaries and stuck them in front of (or made them a part of) an electrospray ionization source. In that regard, it is very surprising that more commercial capillary LC columns aren’t currently available for purchase. Without some investment by a major player to create a robust capillary column line, such technology will not likely be adapted by major industries, such as pharmaceutical companies, who rely on a consistent technology being available from year to year. Along a similar vein, those commercial manufacturers who are beginning to offer chip-based LC formats will also likely have to supply all columns for their instrument, due to unique aspects of instrument construction. This will potentially stifle an industry that has prided itself on being able to use a very wide range of columns from many different manufacturers, some of which are better for some applications than others.
References
Kevin A. Schug is a Full Professor and Shimadzu Distinguished Professor of Analytical Chemistry in the Department of Chemistry and Biochemistry at The University of Texas (UT) at Arlington. He joined the faculty at UT Arlington in 2005 after completing a Ph.D. in chemistry at Virginia Tech under the direction of Prof. Harold M. McNair and a postdoctoral fellowship at the University of Vienna under Prof. Wolfgang Lindner. Research in the Schug group spans fundamental and applied areas of separation science and mass spectrometry. Schug was named the LCGC Emerging Leader in Chromatography in 2009 and the 2012 American Chemical Society Division of Analytical Chemistry Young Investigator in Separation Science. He is a fellow of both the U.T. Arlington and U.T. System-Wide Academies of Distinguished Teachers.
E-mail:kschug@uta.eduWebsite:www.chromatographyonline.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.